Maran Thamilarasan is a Cardiology physician affiliated with Cleveland Clinic. OpenAlex indexes 115 publications with 3,974 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
800-223-2273Registry record last updated 22 Feb 2008.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.8%Beta blocker25.2%Metoprolol Succinate74%Carvedilol12%Metoprolol Tartrate11%Atenolol3%Part D<11 patientsStatin12.6%Atorvastatin Calcium60%Rosuvastatin Calcium36%Pravastatin Sodium4%Part D<11 patients+ 10 more classes in this area
Blood & clotting
8.8%Factor Xa inhibitor5.7%Eliquis100%Part D≥28 patientsVitamin K antagonist1.5%Warfarin Sodium100%Part D≥11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
6.8%SGLT2 inhibitor4.6%Jardiance100%Part D≥22 patientsPotassium supplement1.5%Potassium Chloride100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Real-World Artificial Intelligence–Based Electrocardiographic Analysis to Diagnose Hypertrophic Cardiomyopathy
JACC. Clinical electrophysiology
2025 - Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center
Progress in Cardiovascular Diseases
2024 - Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
American Journal of Cardiovascular Drugs
2024 - Echocardiographic Changes Following Surgical Myectomy in Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the SPIRIT‐HCM Study
Journal of the American Heart Association
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”